Cargando…
Plasma Fibroblast Growth Factor 23: Clinical Correlates and Association With Cardiovascular Disease and Mortality in the Framingham Heart Study
BACKGROUND: Fibroblast growth factor 23 (FGF23) is emerging as a novel biomarker of bone metabolism, chronic kidney disease, and cardiovascular disease (CVD). However, its clinical correlates and potential predictive role in a community‐based setting are incompletely understood. METHODS AND RESULTS:...
Autores principales: | Haring, Robin, Enserro, Danielle, Xanthakis, Vanessa, Mitchell, Gary F., Benjamin, Emelia J., Hamburg, Naomi M., Sullivan, Lisa, Nauck, Matthias, Wallaschofski, Henri, Vasan, Ramachandran S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015386/ https://www.ncbi.nlm.nih.gov/pubmed/27385427 http://dx.doi.org/10.1161/JAHA.116.003486 |
Ejemplares similares
-
Twenty‐Year Trends in the American Heart Association Cardiovascular Health Score and Impact on Subclinical and Clinical Cardiovascular Disease: The Framingham Offspring Study
por: Enserro, Danielle M., et al.
Publicado: (2018) -
Implications of the US Cholesterol Guidelines on Eligibility for Statin Therapy in the Community: Comparison of Observed and Predicted Risks in the Framingham Heart Study Offspring Cohort
por: Andersson, Charlotte, et al.
Publicado: (2015) -
Longitudinal Hemodynamic Correlates of and Sex Differences in the Evolution of Blood Pressure Across the Adult Lifespan: The Framingham Heart Study
por: Mitchell, Gary F., et al.
Publicado: (2023) -
Relative Contributions of Arterial Stiffness and Hypertension to Cardiovascular Disease: The Framingham Heart Study
por: Niiranen, Teemu J., et al.
Publicado: (2016) -
Windkessel Measures Derived From Pressure Waveforms Only: The Framingham Heart Study
por: Behnam, Vira, et al.
Publicado: (2019)